Peptides DB
Research-centric peptide and protocol reference hub
Study 5 of 6Semax literaturePubMed · Observational2026

Digitally Guided Hybrid Maxillary Expansion with Supragingival Mandibular Miniplates for Class III Correction in Late Adolescents: A Pilot Clinical Study.

This pilot study suggests that a digitally guided approach may achieve significant maxillary advancement in late adolescents with Class III malocclusion, though further research is needed to validate these findings.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the semax corpus
1
Preclinical
4
Observational · this one
0
Open-label
0
Randomised
1
Reviews

Summary and findings

This pilot clinical study evaluated a digitally guided protocol combining a hybrid maxillary expander and supragingival mandibular miniplates in ten late adolescents (mean age 16.0 ± 1.3 years) with skeletal Class III malocclusion. The study reported significant maxillary advancement after 12 months of treatment. No significant changes were noted in the mandibular position or angle.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Mean increase in SNA of +6.1°, p < 0.001.2026

Abstract

The authors’ words, as PubMed supplied them

<b>Background:</b> Management of skeletal Class III malocclusion of maxillary origin in late adolescence remains challenging, as conventional tooth-borne orthopedic approaches show reduced effectiveness at advanced stages of skeletal maturation. Minimally invasive, bone-anchored alternatives supported by digital workflows may improve clinical feasibility and patient acceptance. <b>Objective:</b> To describe a digitally guided clinical protocol combining a hybrid maxillary expander and supragingival mandibular miniplates, and to explore skeletal and dentoalveolar outcomes in late adolescents. <b>Methods:</b> This retrospective pilot clinical study included ten late adolescents (mean age 16.0 ± 1.3 years; range 13.8-17.7) in advanced skeletal maturation stages (CS4-CS6) with skeletal Class III malocclusion of maxillary origin. Treatment consisted of a hybrid maxillary expander anchored to palatal miniscrews and custom supragingival mandibular miniplates, placed using a fully digital workflow. Maxillary protraction was performed using a modified Alt-RAMEC protocol followed by continuous intermaxillary elastic traction for 12 months. Pre- and post-treatment cephalometric analyses were conducted. <b>Results:</b> A significant increase in SNA was observed (mean +6.1°, <i>p</i> < 0.001), indicating forward maxillary displacement. The Wits appraisal improved by 3.3 mm (<i>p</i> = 0.007), and the SeMax increased by 2.9 mm (<i>p</i> = 0.0013). No significant changes were found in the SNB or mandibular plane angle. Dentoalveolar effects were limited. <b>Conclusions:</b> Within the limitations of this pilot clinical study, the proposed digitally guided protocol demonstrated clinically relevant maxillary advancement with minimal dentoalveolar side effects and preserved vertical control. This relatively minimally invasive approach compared to conventional subgingival miniplates and orthognathic surgery may represent a feasible treatment option for selected late adolescent patients. Further controlled studies are required to confirm these findings.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the Semax corpus

CEffect of ACTH4-10Pro8-Gly9-Pro10 on anti-inflammatory cytokine (IL-4, IL-10, IL-13) expression in acute spinal cord injury models (male Sprague Dawley rats)biorxiv-preprint · 2025 · Not reported in abstract.AnimalDSemantic Scholar search for SemaxSemanticScholar · 2010DModulation of neuropathological pathways by bioactive peptides and proteins/polypeptides: Targeting oxidative stress in neurodegenerative diseases.PubMed · 2025CThe Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons.PubMed · 2025 · Not reported in abstract.AnimalCEffect of ACTH4-10Pro8-Gly9-Pro10 on anti-inflammatory cytokine (IL-4, IL-10, IL-13) expression in acute spinal cord injury models (male Sprague Dawley rats).PubMed · 2023 · Not reported in abstract.Animal